Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2026 Filed Feb 17, 2026 20:58 UTC |
Wherley Joel LCEO - Vitas Healthcare
|
Exercise / conversionCapital Stock | 0 | $469.56 | $0.00 |
DisclosureSEC source: 0001193125-26-054514 · ownership.xml · nonDerivative · entry 2 Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:58 UTC |
Wherley Joel LCEO - Vitas Healthcare
|
Exercise / conversionCapital Stock | 273 | $469.56 | $128,189.88 |
DisclosureSEC source: 0001193125-26-054514 · ownership.xml · nonDerivative · entry 1 Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:37 UTC |
Witzeman Michael DVP & Chief Financial Officer
|
GrantPerformance Stock Units · Derivative | 1,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054421 · ownership.xml · derivative · entry 6 Witzeman Michael D · CIK 0001699624 · VP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,464 Underlying: Capital Stock · 1,394 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:37 UTC |
Witzeman Michael DVP & Chief Financial Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054421 · ownership.xml · derivative · entry 5 Witzeman Michael D · CIK 0001699624 · VP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,070 Underlying: Capital Stock · 333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:37 UTC |
Witzeman Michael DVP & Chief Financial Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054421 · ownership.xml · derivative · entry 4 Witzeman Michael D · CIK 0001699624 · VP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,403 Underlying: Capital Stock · 333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:37 UTC |
Witzeman Michael DVP & Chief Financial Officer
|
Tax withholdingCapital Stock | 120 | $469.56 | $56,347.20 |
DisclosureSEC source: 0001193125-26-054421 · ownership.xml · nonDerivative · entry 3 Witzeman Michael D · CIK 0001699624 · VP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,953 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:37 UTC |
Witzeman Michael DVP & Chief Financial Officer
|
Exercise / conversionCapital Stock | 0 | $469.56 | $0.00 |
DisclosureSEC source: 0001193125-26-054421 · ownership.xml · nonDerivative · entry 2 Witzeman Michael D · CIK 0001699624 · VP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:37 UTC |
Witzeman Michael DVP & Chief Financial Officer
|
Exercise / conversionCapital Stock | 413 | $469.56 | $193,928.28 |
DisclosureSEC source: 0001193125-26-054421 · ownership.xml · nonDerivative · entry 1 Witzeman Michael D · CIK 0001699624 · VP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
GrantPerformance Stock Units · Derivative | 5,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,256 Underlying: Capital Stock · 5,114 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
Exercise / conversionPerformance Stock Units · Derivative | 2,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,142 Underlying: Capital Stock · 2,187 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
Exercise / conversionPerformance Stock Units · Derivative | 2,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,329 Underlying: Capital Stock · 2,187 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
Tax withholdingCapital Stock | 1,192 | $469.56 | $559,715.52 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,719 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
Exercise / conversionCapital Stock | 0 | $469.56 | $0.00 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 20:14 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
Exercise / conversionCapital Stock | 2,714 | $469.56 | $1,274,385.84 |
DisclosureSEC source: 0001193125-26-054351 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC |
Judkins Brian CVP and Chief Legal Officer
|
GrantPerformance Stock Units · Derivative | 908 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · derivative · entry 6 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,306 Underlying: Capital Stock · 908 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC |
Judkins Brian CVP and Chief Legal Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 283 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · derivative · entry 5 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,398 Underlying: Capital Stock · 283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC |
Judkins Brian CVP and Chief Legal Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 283 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · derivative · entry 4 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,681 Underlying: Capital Stock · 283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC |
Judkins Brian CVP and Chief Legal Officer
|
Tax withholdingCapital Stock | 102 | $469.56 | $47,895.12 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · nonDerivative · entry 3 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,436 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC |
Judkins Brian CVP and Chief Legal Officer
|
Exercise / conversionCapital Stock | 0 | $469.56 | $0.00 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · nonDerivative · entry 2 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 19:33 UTC |
Judkins Brian CVP and Chief Legal Officer
|
Exercise / conversionCapital Stock | 351 | $469.56 | $164,815.56 |
DisclosureSEC source: 0001193125-26-054242 · ownership.xml · nonDerivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. Read SEC document |
| December 26, 2025 Filed Dec 29, 2025 16:25 UTC |
LINDELL ANDREA RDirector
|
GiftCapital Stock | 463 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-334117 · ownership.xml · nonDerivative · entry 1 LINDELL ANDREA R · CIK 0001224643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,539 Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 19:47 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
SaleCapital Stock | 2,000 | $437.55 | $875,100.00 |
DisclosureSEC source: 0001193125-25-296515 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,197 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $436.13 to $438.53. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 20:55 UTC |
LEE SPENCER Sexecutive vice president
|
GiftCapital Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-288067 · ownership.xml · nonDerivative · entry 1 LEE SPENCER S · CIK 0001207134 · executive vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,567 Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 21:27 UTC |
Wherley Joel LCEO - Vitas Healthcare
|
GrantStock Option (right to buy with tandem tax withholding) · Derivative | 17,476 | $443.79 Strike: $443.79 | $7,755,674.04 |
DisclosureSEC source: 0001193125-25-247048 · ownership.xml · derivative · entry 1 Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,819 Underlying: Capital Stock · 17,476 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 20:36 UTC |
LEE SPENCER Sexecutive vice president
|
GrantStock Option (right to buy with tandem tax withholding) · Derivative | 12,759 | $443.79 Strike: $443.79 | $5,662,316.61 |
DisclosureSEC source: 0001193125-25-246890 · ownership.xml · derivative · entry 1 LEE SPENCER S · CIK 0001207134 · executive vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,196 Underlying: Capital Stock · 12,759 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 20:26 UTC |
Judkins Brian CVP and Chief Legal Officer
|
GrantStock Option (right to buy with tandem tax withholding) · Derivative | 15,017 | $443.79 Strike: $443.79 | $6,664,394.43 |
DisclosureSEC source: 0001193125-25-246834 · ownership.xml · derivative · entry 1 Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,067 Underlying: Capital Stock · 15,017 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 20:12 UTC |
HUTTON THOMAS CDirector · vice president
|
GrantStock Option (right to buy with tandem tax withholding) · Derivative | 6,338 | $443.79 Strike: $443.79 | $2,812,741.02 |
DisclosureSEC source: 0001193125-25-246785 · ownership.xml · derivative · entry 1 HUTTON THOMAS C · CIK 0001207131 · Director · vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,718 Underlying: Capital Stock · 6,338 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 20:19 UTC |
Witzeman Michael DVP & Chief Financial Officer
|
GrantStock Option (right to buy with tandem tax withholding) · Derivative | 19,486 | $443.79 Strike: $443.79 | $8,647,691.94 |
DisclosureSEC source: 0001193125-25-246809 · ownership.xml · derivative · entry 1 Witzeman Michael D · CIK 0001699624 · VP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,970 Underlying: Capital Stock · 19,486 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 19:48 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
GrantStock Option (right to buy with tandem tax withholding) · Derivative | 58,672 | $443.79 Strike: $443.79 | $26,038,046.88 |
DisclosureSEC source: 0001193125-25-246713 · ownership.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,159 Underlying: Capital Stock · 58,672 shares Expires 2030-10-21 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/21/2026 Read SEC document |
| September 26, 2025 Filed Sep 29, 2025 15:59 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
SaleCapital Stock | 3,000 | $461.28 | $1,383,840.00 |
DisclosureSEC source: 0001193125-25-222199 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,197 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $460.03 to $462.44. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 15:51 UTC |
GRACE PATRICK PDirector
|
SaleCapital Stock | 150 | $463.39 | $69,508.50 |
DisclosureSEC source: 0001230970-25-000005 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,397 Read SEC document |
| August 05, 2025 Filed Aug 5, 2025 20:42 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
SaleCapital Stock | 2,000 | $428.55 | $857,100.00 |
DisclosureSEC source: 0000950170-25-103149 · ownership.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,197 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.08 to $428.96. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporatio, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 19:24 UTC |
WALSH GEORGE J IIIDirector
|
PurchaseCapital Stock | 200 | $417.10 | $83,420.00 |
DisclosureSEC source: 0000950170-25-102898 · ownership.xml · nonDerivative · entry 1 WALSH GEORGE J III · CIK 0001207140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,523 Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 14:30 UTC |
Westfall Nicholas MichaelExecutive Vice President
|
SaleCapital Stock | 10,012 | $421.91 | $4,224,162.92 |
DisclosureSEC source: 0000950170-25-102520 · ownership.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.00 to $426.16. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:42 UTC |
WALSH GEORGE J IIIDirector
|
GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-075023 · ownership.xml · nonDerivative · entry 1 WALSH GEORGE J III · CIK 0001207140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,323 F1 · acquired: Award of stock Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:33 UTC |
Mount John Meredith Jr.Director
|
GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-075016 · ownership.xml · nonDerivative · entry 1 Mount John Meredith Jr. · CIK 0001942414 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930 F1 · acquired: Award of stock Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:28 UTC |
McCarthy Eileen PDirector
|
GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-075011 · ownership.xml · nonDerivative · entry 1 McCarthy Eileen P · CIK 0001978134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 855 F1 · acquired: Award of stock Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:17 UTC |
LINDELL ANDREA RDirector
|
GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-075001 · ownership.xml · nonDerivative · entry 1 LINDELL ANDREA R · CIK 0001224643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,002 F1 · acquired: Award of stock Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:12 UTC |
Heaney Christopher JDirector
|
GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-074998 · ownership.xml · nonDerivative · entry 1 Heaney Christopher J · CIK 0001811615 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,389 F1 · acquired: Award of stock Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:01 UTC |
DeLyons RonDirector
|
GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-074989 · ownership.xml · nonDerivative · entry 1 DeLyons Ron · CIK 0001811257 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,666 F1 · acquired: Award of stock Read SEC document |
| May 19, 2025 Filed May 20, 2025 16:07 UTC |
GRACE PATRICK PDirector
|
GrantCapital Stock | 277 | $579.04 | $160,394.08 |
DisclosureSEC source: 0000950170-25-074992 · ownership.xml · nonDerivative · entry 1 GRACE PATRICK P · CIK 0001230970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,547 F1 · acquired: Award of stock Read SEC document |
| May 16, 2025 Filed May 19, 2025 13:58 UTC |
LEE SPENCER Sexecutive vice president
|
SaleCapital Stock | 1,500 | $577.99 | $866,985.00 |
DisclosureSEC source: 0000950170-25-073997 · ownership.xml · nonDerivative · entry 1 LEE SPENCER S · CIK 0001207134 · executive vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,627 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.39 to $578.70. The reporting person undertakes to provide Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| May 09, 2025 Filed May 12, 2025 18:42 UTC |
Westfall Nicholas MichaelExecutive Vice President
|
Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 9,956 | $462.04 Strike: $462.04 | $4,600,070.24 |
DisclosureSEC source: 0000950170-25-069033 · ownership.xml · derivative · entry 5 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,172 Underlying: Capital Stock · 9,956 shares Expires 2027-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/31/2023 Read SEC document |
| May 09, 2025 Filed May 12, 2025 18:42 UTC |
Westfall Nicholas MichaelExecutive Vice President
|
Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 16,132 | $445.35 Strike: $445.35 | $7,184,386.20 |
DisclosureSEC source: 0000950170-25-069033 · ownership.xml · derivative · entry 4 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,128 Underlying: Capital Stock · 16,132 shares Expires 2026-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022. Read SEC document |
| May 09, 2025 Filed May 12, 2025 18:42 UTC |
Westfall Nicholas MichaelExecutive Vice President
|
Tax withholdingCapital Stock | 23,000 | $569.70 | $13,103,100.00 |
DisclosureSEC source: 0000950170-25-069033 · ownership.xml · nonDerivative · entry 3 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,012 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 09, 2025 Filed May 12, 2025 18:42 UTC |
Westfall Nicholas MichaelExecutive Vice President
|
Exercise / conversionCapital Stock | 9,956 | $462.04 | $4,600,070.24 |
DisclosureSEC source: 0000950170-25-069033 · ownership.xml · nonDerivative · entry 2 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2025 Filed May 12, 2025 18:42 UTC |
Westfall Nicholas MichaelExecutive Vice President
|
Exercise / conversionCapital Stock | 16,132 | $445.35 | $7,184,386.20 |
DisclosureSEC source: 0000950170-25-069033 · ownership.xml · nonDerivative · entry 1 Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2025 Filed May 8, 2025 13:13 UTC |
LEE SPENCER Sexecutive vice president
|
SaleCapital Stock | 1,500 | $577.86 | $866,790.00 |
DisclosureSEC source: 0000950170-25-066452 · ownership.xml · nonDerivative · entry 1 LEE SPENCER S · CIK 0001207134 · executive vice president 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,127 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.93 to $579.18. The reporting person undertakes to provide Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. Read SEC document |
| May 05, 2025 Filed May 6, 2025 15:59 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative | 10,000 | $471.74 Strike: $471.74 | $4,717,400.00 |
DisclosureSEC source: 0000950170-25-064122 · ownership.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,487 Underlying: Capital Stock · 10,000 shares Expires 2025-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| May 05, 2025 Filed May 6, 2025 15:59 UTC |
MCNAMARA KEVIN JDirector · president and CEO
|
SaleCapital Stock | 1,500 | $576.45 | $864,675.00 |
DisclosureSEC source: 0000950170-25-064122 · ownership.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,197 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.98 to $579.54. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.